Compare OLP & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLP | MASS |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.5M | 498.1M |
| IPO Year | 1995 | 2020 |
| Metric | OLP | MASS |
|---|---|---|
| Price | $20.99 | $9.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $25.83 | $14.00 |
| AVG Volume (30 Days) | 80.9K | ★ 364.9K |
| Earning Date | 11-03-2026 | 11-10-2026 |
| Dividend Yield | ★ 8.55% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $82,740,000.00 | $56,197,000.00 |
| Revenue This Year | $10.43 | $23.13 |
| Revenue Next Year | $2.86 | $18.66 |
| P/E Ratio | $20.20 | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $19.86 | $5.03 |
| 52 Week High | $25.88 | $13.35 |
| Indicator | OLP | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 34.68 | 37.03 |
| Support Level | $20.62 | $6.20 |
| Resistance Level | $23.60 | $11.16 |
| Average True Range (ATR) | 0.58 | 0.88 |
| MACD | -0.06 | -0.23 |
| Stochastic Oscillator | 8.68 | 1.18 |
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.